35 related articles for article (PubMed ID: 28777151)
1. Unexpected PAX8 Immunoreactivity in Metastatic High-grade Breast Cancer.
Kilgore MR; Bosch DE; Adamson KH; Swanson PE; Dintzis SM; Rendi MH
Appl Immunohistochem Mol Morphol; 2019 Oct; 27(9):637-643. PubMed ID: 30358609
[TBL] [Abstract][Full Text] [Related]
2. Polyclonal PAX8 expression in carcinomas of the biliary tract - Frequent non-specific staining represents a potential diagnostic pitfall.
Zong Y; Xiong Y; Dresser K; Yang M; Bledsoe JR
Ann Diagn Pathol; 2021 Aug; 53():151762. PubMed ID: 34102541
[TBL] [Abstract][Full Text] [Related]
3. Abcam Monoclonal Egr-1 ab133695 is an effective primary antibody replacement for Santa Cruz sc-189 polyclonal Egr-1 in songbirds.
Scully EN; Sanchez JM; Sturdy CB
Heliyon; 2019 Nov; 5(11):e02938. PubMed ID: 31844776
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of PAX8 in small cell lung cancer.
Tao F; Zhu H; Xu J; Guo Y; Wang X; Shao L; Pan D; Li G; Fang R
Heliyon; 2024 Apr; 10(7):e28251. PubMed ID: 38596099
[TBL] [Abstract][Full Text] [Related]
5. An Unlikely Source of Iodine Uptake: A Bronchogenic Cyst Masquerading as Metastatic Thyroid Cancer.
Dillon M; Zielinski R; Worth J; Sanders M; Ibrahim O; Vedere T
JCEM Case Rep; 2024 Mar; 2(3):luae042. PubMed ID: 38495395
[TBL] [Abstract][Full Text] [Related]
6. Carcinoma of unknown primary (CUP): an update for histopathologists.
Beauchamp K; Moran B; O'Brien T; Brennan D; Crown J; Sheahan K; Cotter MB
Cancer Metastasis Rev; 2023 Dec; 42(4):1189-1200. PubMed ID: 37394540
[TBL] [Abstract][Full Text] [Related]
7. Napsin A Expression in Subtypes of Thyroid Tumors: Comparison with Lung Adenocarcinomas.
Wu J; Zhang Y; Ding T; Cheng R; Gong W; Guo Y; Luo Y; Pan Y; Zhai Q; Sun W; Lin D; Sun B
Endocr Pathol; 2020 Mar; 31(1):39-45. PubMed ID: 31788765
[TBL] [Abstract][Full Text] [Related]
8. [Clinicopathologic features of primary renal neuroendocrine carcinoma].
Wang XH; Lu X; He B; Jiang YX; Yu WJ; Wang H; Zhang W; Li YJ
Zhonghua Bing Li Xue Za Zhi; 2018 Nov; 47(11):851-856. PubMed ID: 30423609
[No Abstract] [Full Text] [Related]
9. Recent advances in histogenesis research of lung neuroendocrine cancers: Evidence obtained from functional analyses of primitive neural/neuroendocrine cell-specific transcription factors.
Yazawa T
Pathol Int; 2015 Jun; 65(6):277-85. PubMed ID: 25708144
[TBL] [Abstract][Full Text] [Related]
10. Does Strong and Diffuse PAX-8 Positivity Occur in Primary Lung Carcinoma? An Immunohistochemical Study of 418 Cases and Review of the Literature.
McHugh KE; Arrossi AV; Farver CF; Mukhopadhyay S
Appl Immunohistochem Mol Morphol; 2019 Feb; 27(2):140-146. PubMed ID: 28777151
[TBL] [Abstract][Full Text] [Related]
11. Undifferentiated Carcinoma of the Endometrium: An Expanded Immunohistochemical Analysis Including PAX-8 and Basal-Like Carcinoma Surrogate Markers.
Ramalingam P; Masand RP; Euscher ED; Malpica A
Int J Gynecol Pathol; 2016 Sep; 35(5):410-8. PubMed ID: 26598976
[TBL] [Abstract][Full Text] [Related]
12. Expression of neuroendocrine markers in non-neuroendocrine endometrial carcinomas.
Moritz AW; Schlumbrecht MP; Nadji M; Pinto A
Pathology; 2019 Jun; 51(4):369-374. PubMed ID: 31040050
[TBL] [Abstract][Full Text] [Related]
13. PAX-5 expression in pulmonary neuroendocrine neoplasms: its usefulness in surgical and fine-needle aspiration biopsy specimens.
Sica G; Vazquez MF; Altorki N; Port J; Lee PC; Liu Y; Hyjek E; Saqi A
Am J Clin Pathol; 2008 Apr; 129(4):556-62. PubMed ID: 18343782
[TBL] [Abstract][Full Text] [Related]
14. P63 expression in lung carcinoma: a tissue microarray study of 408 cases.
Au NH; Gown AM; Cheang M; Huntsman D; Yorida E; Elliott WM; Flint J; English J; Gilks CB; Grimes HL
Appl Immunohistochem Mol Morphol; 2004 Sep; 12(3):240-7. PubMed ID: 15551738
[TBL] [Abstract][Full Text] [Related]
15. Immunophenotypic and prognostic analysis of PAX8 and TTF-1 expressions in neuroendocrine carcinomas of thymic origin: A comparative study with their pulmonary counterparts.
Bi Y; Deng Y; Li S; Zhou X; Chen Y; Ma D; Mao X; Guan Y; Chen J; Meng Y
J Surg Oncol; 2016 Nov; 114(6):697-702. PubMed ID: 27761900
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
